Background: Research investigating treatments and interventions for cognitive decline fail due to difficulties in accurately recognizing behavioral signatures in the presymptomatic stages of the disease. For this validation study, we took our previously constructed digital biomarker-based prognostic models and focused on generalizability and robustness of the models. Method: We validated prognostic models characterizing subjects using digital biomarkers in a longitudinal, multi-site, 40-month prospective study collecting data in memory clinics, general practitioner offices, and home environments. Results: Our models were able to accurately discriminate between healthy subjects and individuals at risk to progress to dementia within 3 years. The model was also able to differentiate between people with or without amyloid neuropathology and classify fast and slow cognitive decliners with a very good diagnostic performance. Conclusion: Digital biomarker prognostic models can be a useful tool to assist large-scale population screening for the early detection of cognitive impairment and patient monitoring over time.

Digital biomarker-based individualized prognosis for people at risk of dementia / Buegler, M.; Harms, R. L.; Balasa, M.; Meier, I. B.; Exarchos, T.; Rai, L.; Boyle, R.; Tort, A.; Kozori, M.; Lazarou, E.; Rampini, M.; Cavaliere, C.; Vlamos, P.; Tsolaki, M.; Babiloni, C.; Soricelli, A.; Frisoni, G.; Sanchez-Valle, R.; Whelan, R.; Merlo-Pich, E.; Tarnanas, I.. - In: ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING. - ISSN 2352-8729. - 12:1(2020). [10.1002/dad2.12073]

Digital biomarker-based individualized prognosis for people at risk of dementia

Babiloni C.;
2020

Abstract

Background: Research investigating treatments and interventions for cognitive decline fail due to difficulties in accurately recognizing behavioral signatures in the presymptomatic stages of the disease. For this validation study, we took our previously constructed digital biomarker-based prognostic models and focused on generalizability and robustness of the models. Method: We validated prognostic models characterizing subjects using digital biomarkers in a longitudinal, multi-site, 40-month prospective study collecting data in memory clinics, general practitioner offices, and home environments. Results: Our models were able to accurately discriminate between healthy subjects and individuals at risk to progress to dementia within 3 years. The model was also able to differentiate between people with or without amyloid neuropathology and classify fast and slow cognitive decliners with a very good diagnostic performance. Conclusion: Digital biomarker prognostic models can be a useful tool to assist large-scale population screening for the early detection of cognitive impairment and patient monitoring over time.
2020
Altoida Neuro Motor Index; Alzheimer's disease; artificial intelligence; augmented reality; cognitive aging; digital biomarker; machine learning; risk prediction
01 Pubblicazione su rivista::01a Articolo in rivista
Digital biomarker-based individualized prognosis for people at risk of dementia / Buegler, M.; Harms, R. L.; Balasa, M.; Meier, I. B.; Exarchos, T.; Rai, L.; Boyle, R.; Tort, A.; Kozori, M.; Lazarou, E.; Rampini, M.; Cavaliere, C.; Vlamos, P.; Tsolaki, M.; Babiloni, C.; Soricelli, A.; Frisoni, G.; Sanchez-Valle, R.; Whelan, R.; Merlo-Pich, E.; Tarnanas, I.. - In: ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING. - ISSN 2352-8729. - 12:1(2020). [10.1002/dad2.12073]
File allegati a questo prodotto
File Dimensione Formato  
Buegler_Digital-biomarker-based_2020.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.41 MB
Formato Adobe PDF
1.41 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1497154
Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 30
social impact